Dr. Wallace is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Massachusetts General Hospital
55 Fruit St.
Boston, MA 02114Phone+1 617-726-2865
Education & Training
- Harvard School of Public HealthM.Sc., Epidemiology, 2014 - 2017
- Massachusetts General HospitalFellowship, Rheumatology, 2013 - 2015
- Massachusetts General HospitalResidency, Internal Medicine, 2010 - 2013
- Georgetown University School of MedicineClass of 2010
- Cornell UniversityB.A., History, Distinction in All Subjects, 2002 - 2006
Certifications & Licensure
- ME State Medical License Current
- MA State Medical License 2012 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- NIH Loan Repayment Program NIAMS, 2016
- Nomination, Fokko van der Woude Memorial Fund Prize 17th Int’l Vasculitis and ANCA Workshop, 2015
- Distinguished Fellow Award American College of Rheumatology, 2015
- Join now to see all
Publications & Presentations
PubMed
- 632 citationsInternational Consensus Guidance Statement on the Management and Treatment of IgG4-Related DiseaseArezou Khosroshahi, Zachary S. Wallace, J. L. Crowe, Takashi Akamizu, Atsushi Azumi
Arthritis & Rheumatology. 2015-07-01 - 6 citationsIgG4-related disease as a variable-vessel vasculitis: A case series of 13 patients with medium-sized coronary artery involvement.Guy Katz, Sandeep H Hedgire, James R Stone, Sebastian Perez-Espina, Ana Fernandes
Seminars in Arthritis and Rheumatism. 2023-06-01 - 33 citationsNationwide Trends in Hospitalizations and In-Hospital Mortality in Granulomatosis With Polyangiitis (Wegener's).Zachary S. Wallace, Na Lu, Eli M. Miloslavsky, Sebastian Unizony, John H. Stone
Arthritis Care & Research. 2017-04-28
Journal Articles
- An international, multispecialty validation study of the IgG4-related disease responder indexWallace ZS, Khosroshahi A, Carruthers MD, Perugino CA, Choi H, Campochiaro C, Culver EL, Cortazar F, Della-Torre E, Ebbo M, Fernandes A, Frulloni L, Hart P, Karadag O,..., Arthritis Care Res, 1/18/2018
- Barriers and facilitators of mentoring for trainees and early career investigators in rheumatology research: Current state, identification of needs, and roadmap to an ...Ogdie A, Sparks JA, Angeles-Han ST, Bush K, Castelino FV, Golding A, Jiang Y, Kahlenberg JM, Kim AHJ, Lee YC, Machireddy K, Ombrello MJ, Shah AA, Wallace ZS, Nigrovic ..., Arthritis Care Res, 1/1/2018
- Lymphomas in IgG4-related disease: clinicopathologic features in a Western populationBledsoe J, Wallace ZS, Stone JH, Deshpande V, Ferry JA, Virchows Arch, 1/28/2017
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Multicentric Castleman’s Disease and IgG4-RD: An International Case Exchange ExerciseWallace Z, Third International Symposium on IgG4-Related Disease, Maui, HI, 1/1/2017
- A Trial of XmAb 5871, a Reversible Inhibitor of CD19+ Cells in IgG4-Related DiseaseWallace Z, American College of Rheumatology Annual Meeting, San Diego, CA, 1/1/2017
- Rituximab for the Treatment of IgG4-related and Idiopathic Retroperitoneal Fibrosis.Wallwork R, Wallace ZS, Perugino C, Sharma A, Stone JH, American College of Rheumatology Annual Meeting, San Diego, CA, 1/1/2017
- Join now to see all
Lectures
- Cluters in IgG4-RD1/1/2018
- IgG4-Related Disease: A Rapidly Evolving FieldGeorgetown University, Washington, DC - 1/1/2017
- A 64-year-old man with fevers, arthralgias, and testicular painMassachusetts General Hospital - 1/1/2017
- Join now to see all
Authored Content
- Reducing Glucocorticoid Duration in Anca-Associated Vasculitis: A Pilot TrialFebruary 2018
- Reducing Glucocorticoid Duration in Anca-Associated Vasculitis: A Pilot TrialFebruary 2018
- Reducing Glucocorticoid Duration in Anca-Associated Vasculitis: A Pilot TrialFebruary 2018
Press Mentions
- ANCA-Associated Vasculitis: Parsing the Kidney ComplicationsMarch 3rd, 2023
- A World of Difference: Updates from the Global Rheumatology SummitJanuary 20th, 2023
- Vaccination Cuts Long COVID Risk for Rheumatic Disease PatientsDecember 7th, 2022
- Join now to see all
Grant Support
- Impact of ANCA Type and Rituximab vs. Cyclophosphamide on Cardiovascular Risk, Mortality, and Quality-Adjusted Life Years inANCA-Associated VasculitisNIAMS2018–2023
- Phenotypes and Biomarkers of IgG4-Related DiseaseRRF2016–2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: